Philotimo Fund, LP 13D and 13G filings for Aytu BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-26 5:36 pm Purchase | 2025-06-06 | 13G | Aytu BioPharma, Inc. AYTU | Philotimo Fund, LP | 573,358 6.400% | 407,090 (+244.84%) | Filing |
| 2025-06-26 5:31 pm Sale | 2025-05-22 | 13G | Aytu BioPharma, Inc. AYTU | Philotimo Fund, LP | 166,268 2.700% | -468,805 (-73.82%) | Filing |
| 2025-06-26 5:18 pm Purchase | 2025-05-15 | 13G | Aytu BioPharma, Inc. AYTU | Philotimo Fund, LP | 635,073 10.300% | 253,268 (+66.33%) | Filing |
| 2025-06-26 5:01 pm Purchase | 2025-05-14 | 13G | Aytu BioPharma, Inc. AYTU | Philotimo Fund, LP | 381,805 6.200% | 381,805 (New Position) | Filing |